USX:TEAR - TearLab Corp (USD 0.02) TearLab Corp
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance
Note: This stock seems to be inactive

USD 0.0202    -0.010 (-32.67%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

1 Apr 2020


1 Apr 2020

Day Change: -0.010 (-32.67%)

52 Wk Range: 0.0201 - 1.94

Day's Range: 0.0202 - 0.03

Last Volume: 7,125

Current Yield: 0%

Projected Yield: 0%

Open: USD 0.02657

8 Apr 2020

Metric TEAR S.Median
Beta 1.53 0.8
VaR 387.16 36.45
E.Shortfall 387.16 62.45
Liquidity 17.46K 41.72K


1 Apr 2020

PE: -0.053

Market Cap: 252.5K

Price Over Book: -0.01

Price Over Sales: 0.01

Return On Assets: -30%

Return On Equity: 19.2%

Price Over NAV: [Friends Only]


CEO: Joseph Jensen

Headquarters: SAN DIEGO

Employees: 34

Sector: Health Technology

Industry: Medical Specialties

Useful Links


TearLab Corporation operates as an in-vitro diagnostic company in the United States. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company's system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.